In MDS and AML, EZH2 expression is also regulated by mutations in spliceosome genes, such as SRSF2 and U2AF1, which cause mis-splicing of EZH2, leading to degradation of variant EZH2 mRNAs via nonsense-mediated decay [63,64]. This evidence concerns the gene EZH2 and acute myeloid leukemia.